Buprenorphine is an effective yet underused treatment for opioid use disorder (OUD). Researchers set out with this objective – to evaluate the feasibility (acceptability, tolerability, and safety) of 7-day injectable extended-release buprenorphine in patients with minimal to mild opioid withdrawal.
Full study: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820859
0 Comments